Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder.

Chitty KM, Lagopoulos J, Lee RS, Hickie IB, Hermens DF.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1348-63. doi: 10.1016/j.euroneuro.2013.07.007. Epub 2013 Aug 2. Review.

PMID:
23968965
2.

Hippocampal glutamatergic/NMDA receptor functioning in bipolar disorder: A study combining mismatch negativity and proton magnetic resonance spectroscopy.

Chitty KM, Lagopoulos J, Hickie IB, Hermens DF.

Psychiatry Res. 2015 Aug 30;233(2):88-94. doi: 10.1016/j.pscychresns.2015.05.002. Epub 2015 May 12.

PMID:
26070970
3.

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.

Gigante AD, Bond DJ, Lafer B, Lam RW, Young LT, Yatham LN.

Bipolar Disord. 2012 Aug;14(5):478-87. doi: 10.1111/j.1399-5618.2012.01033.x. Review.

PMID:
22834460
4.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
5.

Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study.

Senaratne R, Milne AM, MacQueen GM, Hall GB.

Psychiatry Res. 2009 Jun 30;172(3):205-9. doi: 10.1016/j.pscychresns.2008.07.007. Epub 2009 Apr 21.

PMID:
19386476
6.

Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study.

Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF.

Neuropsychopharmacology. 2009 Jun;34(7):1810-8. doi: 10.1038/npp.2009.2. Epub 2009 Feb 4.

7.

Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.

Rowland LM, Summerfelt A, Wijtenburg SA, Du X, Chiappelli JJ, Krishna N, West J, Muellerklein F, Kochunov P, Hong LE.

JAMA Psychiatry. 2016 Feb;73(2):166-74. doi: 10.1001/jamapsychiatry.2015.2680.

8.

Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P, Randall E, Lyoo IK, Renshaw PF.

J Affect Disord. 2007 Apr;99(1-3):19-25. Epub 2006 Sep 26.

9.

Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.

Ongür D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF.

Biol Psychiatry. 2008 Oct 15;64(8):718-26. doi: 10.1016/j.biopsych.2008.05.014. Epub 2008 Jul 7.

10.

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F.

Biol Psychiatry. 2000 Feb 15;47(4):305-13.

PMID:
10686265
11.

Hippocampal neurochemical markers in bipolar disorder patients following the first-manic episode: A prospective 12-month proton magnetic resonance spectroscopy study.

Silveira LE, Bond DJ, MacMillan EL, Kozicky JM, Muralidharan K, Bücker J, Rosa AR, Kapczinski F, Yatham LN.

Aust N Z J Psychiatry. 2017 Jan;51(1):65-74. doi: 10.1177/0004867415623859. Epub 2016 Jul 11.

PMID:
26792829
12.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
13.

Could glutamate spectroscopy differentiate bipolar depression from unipolar?

Taylor MJ.

J Affect Disord. 2014;167:80-4. doi: 10.1016/j.jad.2014.05.019. Epub 2014 May 23.

PMID:
25082118
14.

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE.

Schizophr Bull. 2013 Jan;39(1):120-9. doi: 10.1093/schbul/sbr069. Epub 2011 Jul 11. Review.

15.

Investigating the role of glutathione in mismatch negativity: An insight into NMDA receptor disturbances in bipolar disorder.

Chitty KM, Lagopoulos J, Hickie IB, Hermens DF.

Clin Neurophysiol. 2015 Jun;126(6):1178-84. doi: 10.1016/j.clinph.2014.09.025. Epub 2014 Oct 5.

PMID:
25454340
16.

Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.

Strawn JR, Patel NC, Chu WJ, Lee JH, Adler CM, Kim MJ, Bryan HS, Alfieri DC, Welge JA, Blom TJ, Nandagopal JJ, Strakowski SM, DelBello MP.

J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):642-51. doi: 10.1016/j.jaac.2012.03.009. Epub 2012 May 5.

17.

Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex.

Michael N, Erfurth A, Ohrmann P, Gössling M, Arolt V, Heindel W, Pfleiderer B.

Psychopharmacology (Berl). 2003 Jul;168(3):344-6. Epub 2003 Apr 9.

PMID:
12684737
18.

Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder.

Michael N, Erfurth A, Pfleiderer B.

Psychiatry Res. 2009 Apr 30;172(1):78-81. doi: 10.1016/j.pscychresns.2009.01.002. Epub 2009 Feb 23.

PMID:
19239983
19.

Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy.

Cecil KM, DelBello MP, Morey R, Strakowski SM.

Bipolar Disord. 2002 Dec;4(6):357-65.

PMID:
12519095
20.

Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations.

Castillo M, Kwock L, Courvoisie H, Hooper SR.

AJNR Am J Neuroradiol. 2000 May;21(5):832-8.

Supplemental Content

Support Center